The HMGXB4 Knockout HAP1 Polyclonal Cells provide a CRISPR/Cas9-edited polyclonal cell population with targeted disruption of HMGXB4. HMGXB4 encodes an HMG-box transcription factor that modulates gene expression through DNA binding and chromatin interactions, with roles in Wnt/??-catenin signaling. This polyclonal knockout pool, derived from the HAP1 near-haploid cell line, offers a robust loss-of-function model for functional studies, free from clonal bias.
HAP1 cells, originating from the KBM-7 chronic myeloid leukemia line, feature a near-haploid karyotype that simplifies genetic analyses. Their stable, fibroblast-like morphology and rapid growth support high-throughput assays and knockout screens. Haploidy ensures that single-gene disruptions produce clear phenotypes, enabling direct genotype-phenotype correlations. This background minimizes functional redundancy, making HAP1 a gold standard for gene function studies, particularly in cancer biology and signal transduction.
HMGXB4 participates in chromatin organization and transcriptional regulation, acting as a cofactor in Wnt signaling. It interacts with ??-catenin (CTNNB1), TCF7L2, and LEF1 on target gene promoters. Activated by WNT3A through FZD/LRP5/6, the pathway stabilizes CTNNB1 via DVL and GSK3B inhibition. HMGXB4 then modulates expression of AXIN2, CCND1, and MYC. Its interactions with chromatin remodeling complexes confer context-dependent control over proliferation and differentiation.
Combining HMGXB4 knockout with the HAP1 haploid background creates a powerful system for investigating transcriptional control mechanisms. The absence of a second allele eliminates confounding wild-type expression, enhancing signal-to-noise in phenotypic assays. This model is particularly suited for dissecting Wnt pathway dynamics, as HAP1 cells retain a functional Wnt signaling cascade. Researchers can explore how HMGXB4 loss affects chromatin landscape and target gene transcription without interference from redundant HMG-box factors.
Research applications encompass functional genomics (RNA-seq, ChIP-qPCR), Wnt pathway interrogation using luciferase reporters and co-immunoprecipitation of CTNNB1/LEF1 complexes, and cancer cell biology (proliferation, migration/invasion assays). The polyclonal format supports bulk population studies and drug target validation via high-content screening for HMGXB4-related pathways. These cells advance research into transcriptional dysregulation in developmental disorders and leukemogenesis. For further inquiries, contact Ascent Research.
